Literature DB >> 19374904

Testosterone treatment diminishes sickness behavior in male songbirds.

Noah T Ashley1, Quentin R Hays, George E Bentley, John C Wingfield.   

Abstract

Males of many vertebrate species are typically more prone to disease and infection than female conspecifics, and this sexual difference is partially influenced by the immunosuppressive properties of testosterone (T) in males. T-induced immunosuppression has traditionally been viewed as a pleiotropic handicap, rather than an adaptation. Recently, it has been hypothesized that suppression of sickness behavior, or the symptoms of infection, may have adaptive value if sickness interferes with the expression of T-mediated behaviors important for male reproductive success. We conduct a classic hormone replacement experiment to examine if T suppresses sickness behavior in a seasonally-breeding songbird, Gambel's white-crowned sparrow (Zonotrichia leucophrys gambelii). Triggered experimentally by bacterial lipopolysaccharide (LPS), sickness behavior includes decreased activity, anorexia, and weight loss. Gonadectomized (GDX) males that were treated with silastic implants filled with T exhibited suppression of behavioral and physiological responses to LPS compared to GDX and sham-GDX controls given empty implants. Sickness responses of control groups were statistically indistinguishable. T-implanted birds had significantly higher plasma T than control groups and levels were within the range associated with aggressive interactions during male-to-male contests. These findings imply that suppression of sickness behavior could occur when T is elevated to socially-modulated levels. Alternatively, it is possible that this suppressive effect is mediated through a stress-induced mechanism, as corticosterone levels were elevated in T-implanted subjects compared to controls. We propose that males wounded and infected during contests may gain a brief selective advantage by suppressing sickness responses that would otherwise impair competitive performance. The cost of immunosuppression would be manifested in males through an increased susceptibility to disease, which is presumably offset by capitalizing upon limited reproductive opportunities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374904     DOI: 10.1016/j.yhbeh.2009.04.003

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  7 in total

Review 1.  When is it socially acceptable to feel sick?

Authors:  Patricia C Lopes
Journal:  Proc Biol Sci       Date:  2014-08-07       Impact factor: 5.349

Review 2.  Neuroendocrine control of photoperiodic changes in immune function.

Authors:  Zachary M Weil; Jeremy C Borniger; Yasmine M Cisse; Bachir A Abi Salloum; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2014-10-18       Impact factor: 8.606

Review 3.  Neuroendocrine-immune circuits, phenotypes, and interactions.

Authors:  Noah T Ashley; Gregory E Demas
Journal:  Horm Behav       Date:  2016-10-17       Impact factor: 3.587

4.  Behavioral effects of social challenges and genomic mechanisms of social priming: What's testosterone got to do with it?

Authors:  Kimberly A Rosvall; Mark P Peterson
Journal:  Curr Zool       Date:  2014-12-01       Impact factor: 2.624

5.  Female presence does not increase testosterone but still ameliorates sickness behaviours in male Japanese quail.

Authors:  Brenna M G Gormally; Kaelyn Bridgette; Aubrey Emmi; Delilah Schuerman; Patricia C Lopes
Journal:  R Soc Open Sci       Date:  2022-05-24       Impact factor: 3.653

6.  Robust behavioral effects of song playback in the absence of testosterone or corticosterone release.

Authors:  Kimberly A Rosvall; Dustin G Reichard; Stephen M Ferguson; Danielle J Whittaker; Ellen D Ketterson
Journal:  Horm Behav       Date:  2012-07-28       Impact factor: 3.587

7.  Gut Endotoxin Leading to a Decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men.

Authors:  Kelton Tremellen
Journal:  Basic Clin Androl       Date:  2016-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.